{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:42:35Z","timestamp":1788298955861,"version":"build-2803163510"},"reference-count":83,"publisher":"Swets & Zeitlinger Publishers","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Ophthalmology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1076\/soph.17.1.39.10292","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T04:34:51Z","timestamp":1047530091000},"page":"39-46","source":"Crossref","is-referenced-by-count":31,"title":["Treatment of ischemic optic neuropathy"],"prefix":"10.1076","volume":"17","author":[{"given":"Anthony C.","family":"Arnold","sequence":"first","affiliation":[{"name":"Jules Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Wisconsin Hospital and Clinics, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"191","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":"MacMichael IM Cullen JF. Pathology of ischaemic optic neuropathy. In: Cant JS ed. The Optic Nerve Proceedings of the Second William MacKenzie Memorial Symposium. London: Henry Kimpton. 1972;108\u2013116."},{"key":"e_1_2_1_3_1","volume-title":"Ann Intern Med","author":"Hunder GG","unstructured":"Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis. Ann Intern Med. 1975;82:613\u2013 618."},{"key":"e_1_2_1_4_1","first-page":"1779","volume-title":"Ophthalmology","author":"Liu GT","year":"1994","unstructured":"Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Ophthalmology. 1994;101:1779\u2013 1785."},{"key":"e_1_2_1_5_1","first-page":"550","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello PD","year":"1993","unstructured":"Aiello PD, Trautmann JC, McPhee TJ, Kunselman BS, Hunder GC. Visual prognosis in giant cell arteritis. Oph- thalmology. 1993;100:550\u2013555.","journal-title":"Oph- thalmology"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-2-200101160-00010"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Levy MH Wong KL Chen MC Weitzner RI Yonker RA Kaine JL. The adjuvant use of optic nerve sheath fenestra- tion in biopsy proven temporal arteritis. Ophthalmology . 1992;99(Suppl):109.","DOI":"10.1016\/S0161-6420(92)31932-3"},{"key":"e_1_2_1_8_1","first-page":"568","article-title":"Systemic lysis therapy in retinal vascular occlusions","volume":"95","author":"Hattenbach LO.","year":"1998","unstructured":"Hattenbach LO. Systemic lysis therapy in retinal vascular occlusions. Ophthalmology. 1998;95:568\u2013575.","journal-title":"Ophthalmology"},{"key":"e_1_2_1_9_1","volume-title":"Surg Neurol","author":"Wirostko WJ","unstructured":"Wirostko WJ, Pulido JS, Hendrix LE. Selective throm- bolysis of central retinal artery occlusion without long- term systemic heparinization. Surg Neurol. 1998;50:408\u2013 410."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.11.2020"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0248-8663(96)80824-1"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1990.4"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)73080-6"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1990.3"},{"key":"e_1_2_1_15_1","first-page":"1","article-title":"Les pseudo-papillites d\u2019origin vascu- laire","volume":"200","author":"Saraux H","year":"1967","unstructured":"Saraux H, Murat JP. Les pseudo-papillites d\u2019origin vascu- laire. Ann Ocul. 1967;200:1\u201319.","journal-title":"Ann Ocul"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1974.03900060449003"},{"key":"e_1_2_1_17_1","first-page":"283","article-title":"Nor- epinephrine therapy of ischemic optic neuropathy","volume":"1","author":"Kollarits CR","year":"1981","unstructured":"Kollarits CR, McCarthy RW, Corrie WS, Swann ER. Nor- epinephrine therapy of ischemic optic neuropathy. J Clin Neuro-ophthalmol. 1981;1:283\u2013288.","journal-title":"J Clin Neuro-ophthalmol"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.58.12.990"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-009-9611-3_6"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1965.00970030317004"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(86)33617-0"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72114-2"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070020825022"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)76779-0"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1991.01080050081034"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520320035038"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140566007"},{"key":"e_1_2_1_28_1","volume-title":"Ophthalmology","author":"Johnson LN","unstructured":"Johnson LN, Guy ME, Krohel GB et al. Levodopa may improve vision loss in recent-onset nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107:521\u2013 526."},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","unstructured":"Beck RW Ferris FL. Does levodopa improve visual func- tion in NAION? (Letter to the Editor) Ophthalmology . 2000a;107:1431\u20131434.","DOI":"10.1016\/S0161-6420(00)00301-8"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","unstructured":"Hayreh SS. Does levodopa improve visual function in NAION? (Letter to the Editor) Ophthalmology . 2000;107:1434\u20131435.","DOI":"10.1016\/S0161-6420(00)00302-X"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)77065-5"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(94)90145-7"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005173222001"},{"key":"e_1_2_1_34_1","first-page":"2744","article-title":"Effect of lipid peroxidation inhibition on retinal ganglion cell death","volume":"37","author":"Levin LA","year":"1996","unstructured":"Levin LA, Clark JA, Johns LK. Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest Ophthalmol Vis Sci. 1996b;37:2744\u20132749.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200012000-00007"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.7.1607"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.11.1533"},{"key":"e_1_2_1_38_1","volume-title":"Mol Med Today","author":"Schwartz M","unstructured":"Schwartz M, Yoles E, Levin LA. \u201cAxogenic\u201d and \u201csomagenic\u201d neurodegenerative diseases: definitions and therapeutic implications. Mol Med Today. 1999;5:470\u2013 473."},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.2.219"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(80)35283-4"},{"key":"e_1_2_1_41_1","volume-title":"J Neurotrauma","author":"Yoles E","unstructured":"Yoles E, Muller S, Schwartz M. NMDA-receptor antago- nist protects neurons from secondary degeneration after partial optic nerve crush. J Neurotrauma. 1997;14:665\u2013 675."},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.5.1632"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040901"},{"key":"e_1_2_1_44_1","volume-title":"Stroke","author":"Muir KW","unstructured":"Muir KW, Grosset DG. Neuroprotection for acute stroke: making clinical trials work. Stroke. 1999;30:180\u2013 182."},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005173222001"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540440031029"},{"key":"e_1_2_1_47_1","first-page":"1065","article-title":"Slowly progressive ischemic optic neu- ropathy. A clinicopathologic case report","volume":"75","author":"Knox DL","year":"1971","unstructured":"Knox DL, Duke JR. Slowly progressive ischemic optic neu- ropathy. A clinicopathologic case report. Trans Am Acad Ophthalmol Otolaryngol. 1971;75:1065\u20131068.","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)73365-3"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100130484027"},{"key":"e_1_2_1_50_1","first-page":"221","volume-title":"Green WR. Histopathologic studies of ischemic optic neuropathy","author":"Knox DL","year":"2000","unstructured":"Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc. 2000;98:203\u2013220;discussion 221\u2013222."},{"key":"e_1_2_1_51_1","first-page":"764","article-title":"Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma","volume":"41","author":"Pease ME","year":"2000","unstructured":"Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthal- mol Vis Sci. 2000;41:764\u2013774.","journal-title":"Invest Ophthal- mol Vis Sci"},{"key":"e_1_2_1_52_1","first-page":"3460","article-title":"Retrograde axonal trans- port of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats","volume":"41","author":"Quigley HA","year":"2000","unstructured":"Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan- Baumrind LA, Kerrigan DF et al. Retrograde axonal trans- port of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci. 2000;41:3460\u20133466.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_53_1","first-page":"431","article-title":"Chronology of optic nerve head and retinal responses to elevated intraocular pressure","volume":"41","author":"Johnson EC","year":"2000","unstructured":"Johnson EC, Deppmeier LMH, Wentzien SKF, Hsu I, Morrison JC. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest Ophthal- mol Vis Sci. 2000;41:431\u2013442.","journal-title":"Invest Ophthal- mol Vis Sci"},{"key":"e_1_2_1_54_1","first-page":"489","article-title":"Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study","volume":"37","author":"Peinado-Ramon P","year":"1996","unstructured":"Peinado-Ramon P, Salvador M, Villegas-Perez MP, Vidal- Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:489\u2013500.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_55_1","first-page":"65","article-title":"agonists are neuroprotective in a rat model of optic nerve degeneration","volume":"40","author":"Yoles E","year":"1999","unstructured":"Yoles E, Wheeler LA, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 1999;40:65\u201373.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00205-3"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-19-05986.1996"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02592-0"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01393-5"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703369"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2000.0929"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00654-0"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6989(97)00047-3"},{"key":"e_1_2_1_64_1","first-page":"1004","article-title":"Experimental induction of retinal ganglion cell death in adult mice","volume":"40","author":"Li Y","year":"1999","unstructured":"Li Y, Schlamp CL, Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci. 1999;40:1004\u20131008.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_65_1","doi-asserted-by":"crossref","unstructured":"Russelakis-Carneiro M Silveira LC Perry VH. Factors affecting the survival of cat retinal ganglion cells after optic nerve injury. J Neurocytol . 1996;25:393\u2013402.Hare W WoldeMussie E Lai R Ton H Ruiz G Feldmann B et al . Efficacy and safety of memantine an NMDA-type open-channel blocker for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol . 2001;45 Suppl 3: S284\u2013S289;discussion S295\u2013S296.","DOI":"10.1016\/S0039-6257(01)00200-4"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(91)90066-9"},{"key":"e_1_2_1_67_1","first-page":"157","article-title":"Expression of ceruloplasmin in the retina: Induction after retinal ganglion cell axotomy","volume":"39","author":"Levin LA","year":"1998","unstructured":"Levin LA, Geszvain KM. Expression of ceruloplasmin in the retina: Induction after retinal ganglion cell axotomy. Invest Ophthalmol Vis Sci. 1998;39:157\u2013163.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_68_1","volume-title":"Invest Ophthalmol Vis Sci","author":"Levin LA","unstructured":"Levin LA, Schlamp CL, Spieldoch RL, Geszvain KM, Nickells RW. Identification of bcl-2 family genes in the rat retina. Invest Ophthalmol Vis Sci. 1997;38."},{"key":"e_1_2_1_69_1","first-page":"1840","article-title":"Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury","volume":"38","author":"Gao H","year":"1997","unstructured":"Gao H, Qiao X, Hefti F, Hollyfield JG, Knusel B. Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest Ophthalmol Vis Sci. 1997;38:1840\u20131847.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_70_1","volume-title":"FEBS Lett","author":"Kermer P","unstructured":"Kermer P, Klocker N, Labes M, Thomsen S, Srinivasan A, Bahr M. Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo. FEBS Lett. 1999;453:361\u2013 364."},{"key":"e_1_2_1_71_1","volume-title":"J Neurosci","author":"Berkelaar M","unstructured":"Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994;14:4368\u2013 4374."},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199904060-00034"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6585"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1997.tb01534.x"},{"key":"e_1_2_1_75_1","first-page":"774","article-title":"Retinal ganglion cell death in exper- imental glaucoma and after axotomy occurs by apoptosis","volume":"36","author":"Quigley HA","year":"1995","unstructured":"Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in exper- imental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774\u2013786.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/neu.480250408"},{"key":"e_1_2_1_77_1","first-page":"50","article-title":"NAION as a model disease for testing neuroprotective interventions-The BRAION Multi- center Study","volume":"25","author":"Wilhelm B","year":"2001","unstructured":"Wilhelm B, Zrenner E. NAION as a model disease for testing neuroprotective interventions-The BRAION Multi- center Study. Neuro-Ophthalmology. 2001;25:50.","journal-title":"Neuro-Ophthalmology"},{"key":"e_1_2_1_78_1","doi-asserted-by":"crossref","unstructured":"Fazzone HE Kupersmith MJ. Does brimonidine tartrate help NAION? NANOS Annual Meeting 2002.","DOI":"10.1136\/bjo.87.9.1193"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)01301-0"},{"key":"e_1_2_1_80_1","first-page":"250","article-title":"Functional performance of the regenerating visual system. Neuro-Ophthalmology. 2001; 25:47\u201348.KupersmithMJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, Warren FA. Aspirin reduces the incidence of second eye NAION: a restrospective study","volume":"17","author":"Thanos S","year":"1997","unstructured":"Thanos S, Fischer D, Heiduschka P. Functional performance of the regenerating visual system. Neuro-Ophthalmology. 2001; 25:47\u201348.KupersmithMJ, Frohman L, Sanderson M, Jacobs J, Hirschfeld J, Ku C, Warren FA. Aspirin reduces the incidence of second eye NAION: a restrospective study. J Neuro-Ophthalmol. 1997;17:250\u2013253.","journal-title":"J Neuro-Ophthalmol"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1999.90"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)71038-4"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2000.34"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)73478-6"}],"container-title":["Seminars in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1076\/soph.17.1.39.10292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:13:06Z","timestamp":1753099986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1076\/soph.17.1.39.10292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1076\/soph.17.1.39.10292"],"URL":"https:\/\/doi.org\/10.1076\/soph.17.1.39.10292","relation":{},"ISSN":["0882-0538","1744-5205"],"issn-type":[{"value":"0882-0538","type":"print"},{"value":"1744-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}